Work

Combined CDK4/6 and PD-1 Inhibition in Refractory SMARCA4-Deficient Small-Cell Carcinoma of the Ovary, Hypercalcemic Type

Year: 2020

Type: article

Source: JCO Precision Oncology

DOI: 10.1200/po.20.00063

Authors: Elizabeth K. Lee, Katharine M. Esselen, David L. Kolin, Larissa J. Lee, Ursula A. Matulonis, Panagiotis A. Konstantinopoulos

Institutions: Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Dana-Farber Brigham Cancer Center

Language: English

Topic: Chromatin Remodeling and Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: NRG Oncology Network Group Operations Center, Dana-Farber/Harvard Cancer Center Experimental Therapeutics Clinical Trials Network Site (DF/HCC ETCTN Site)

OpenAlex ID: W3038027381

FWCI: 0.973

Cites: 41

Cited by: 30

Related to: 10